A PHASE IB OPEN-LABEL, MULTICENTER STUDY EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF MOSUNETUZUMAB AND A COMBINED REGIMEN OF MOSUNETUZUMAB AND VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date5/04/22 → 13/02/27

Keywords

  • leukemia
  • treatment safety
  • treatment efficacy
  • multicentre trial
  • phase 1 study